Daxxify vs. Jeuveau: A Complete Guide to Modern Neurotoxin Treatments

Neurotoxin injections remain the most-requested aesthetic treatment in the country, and the menu has grown well past the single name most people still use as shorthand. Botox opened the category, but it now shares the room with newer formulations that were engineered to solve specific problems patients kept raising. Two of those newer names, Daxxify and Jeuveau, sit at opposite ends of an interesting spectrum. One was built to last noticeably longer between visits. The other was built to deliver the familiar result at a friendlier price.

At Youth Lab Aesthetics in Meridian, Idaho, we offer both because each one answers a different question. Choosing between them has less to do with which product is objectively stronger and more to do with your schedule, your budget, and how your muscles respond. This guide walks through how each neurotoxin works, where it performs best, and how to think through the decision with an injector who uses both.

What Are Cosmetic Neurotoxins?

Cosmetic neurotoxins are purified forms of botulinum toxin type A, a protein that temporarily interrupts the signal between a nerve and the muscle it controls. When a small, precise dose is placed into a specific facial muscle, that muscle relaxes. The overlying skin stops creasing along its usual fold, and the dynamic lines that form with expression soften.

These lines are the ones that appear when you frown, squint, or raise your brows. The forehead lines, the crow’s feet at the corners of the eyes, and the vertical “11s” between the brows all come from repeated muscle movement. Because every FDA-approved neurotoxin in aesthetics uses the same underlying toxin, the differences between products come down to how each one is formulated, dosed, and stabilized. Those formulation details are exactly where Daxxify and Jeuveau part ways.

How Does Jeuveau Work?

Jeuveau is a botulinum toxin type A product made by Evolus, approved by the FDA in 2019 for moderate to severe frown lines between the eyebrows. Its active ingredient is prabotulinumtoxinA-xvfs, produced through a proprietary purification process. In practice it behaves much like the original neurotoxin most patients already know, which is part of its appeal.

Jeuveau earned an early nickname as the treatment aimed squarely at aesthetics rather than medical use. It was developed specifically for cosmetic wrinkle reduction, and Evolus priced it to compete directly on value. For many patients that combination lands well. The onset sits around two to three days, full effect settles within about two weeks, and results generally hold for three to four months before a maintenance appointment is due.

The muscle-relaxing mechanism is the same one behind every product in this category. Where Jeuveau distinguishes itself is positioning: a modern, cosmetically focused neurotoxin that delivers the classic outcome at a price point that keeps regular upkeep manageable.

How Does Daxxify Work?

Daxxify is a botulinum toxin type A product from Revance, approved by the FDA in 2022 for moderate to severe frown lines. Its active ingredient is daxibotulinumtoxinA-lanm. The headline feature is longevity, and the reason for that longevity comes down to a single design choice.

Most neurotoxins are stabilized with human serum albumin, a blood-derived protein that keeps the toxin intact in the vial. Daxxify replaces that albumin with a custom-engineered synthetic peptide called RTP004. This peptide carries a positive charge that helps the toxin bind more securely at the nerve terminal, which appears to slow the process by which nerve function returns. The result is a treatment that many patients find lasts considerably longer than the traditional three to four month window.

In clinical use, Daxxify results often hold for around six months, and some patients maintain smoothing on frown lines for up to nine months. That extended duration is the main reason a patient might choose it, since fewer visits per year can be a meaningful convenience. Beyond aesthetics, the same longer-acting profile has drawn interest for muscle-related concerns, which is why some patients ask about Daxxify for jaw tension and TMJ during their consultation.

How Long Does Each One Actually Last?

Duration is the difference patients feel most, so it is worth grounding in the trial data rather than marketing language. In the Phase 3 SAKURA 1 and SAKURA 2 studies that supported its approval, Daxxify demonstrated a median duration of therapeutic benefit of 24 weeks, roughly six months, for moderate to severe frown lines. Jeuveau, by comparison, follows the standard neurotoxin timeline of three to four months, similar to the products most patients started with.

Averages are a starting point, not a guarantee. Metabolism, muscle strength, dose, and how expressive you are in the treated area all shape how long a result holds on your face. Someone with strong, active frown muscles may see any neurotoxin fade a little faster, while a lighter, more preventative approach can stretch results at the longer end of the range.

Daxxify vs. Jeuveau: Side by Side

The clearest way to weigh the two is to line up how each product is built and how it behaves once it is placed.

Where Does Each Treatment Shine?

Both products treat the same core concern, the frown lines between the brows, and both are used off the standard glabellar indication for other areas of the upper face in experienced hands. The deciding factor is usually what you value most in the overall experience.

Jeuveau tends to suit patients who:

• Want a dependable, natural-looking refresh at the most budget-friendly price point, especially first-timers testing the waters
• Prefer more frequent touch-ups and like the flexibility of adjusting their look every few months

Daxxify tends to suit patients who:

• Want the longest stretch between appointments and would rather visit two or three times a year than four or five
• Have busy schedules or travel often, where fewer maintenance visits is worth a higher per-session cost